Abstract
Reliable prognostic factors are needed to improve the stratification of patients with lymph node-negative breast cancer to different therapy modalities. We investigated the prognostic value of quantitative histopathology in a retrospective study of 98 “low-risk” breast cancer patients (T1+2N0M0) with a median follow-up of 9 years. An interactive video system and stereological and morphometric techniques were used to obtain estimates of four nuclear features (mean volume, mean profile area, volume fraction, and profile density), and two mitotic counts [mitotic profile frequency (MF) and mitotic profile density (MD)]. All measurements were performed in fields of vision sampled systematically from the whole tumour area of a routine histological section. Histological grade, histological type, and oestrogen receptor (ER) status was reassessed, whereas tumour diameter and age at diagnosis were recorded from the files. We found that all quantitative histopathological variables and ER status were correlated with histological grade. Single-factor prognostic analyses showed a highly significant value of MF (2p=0.001) and a marginally significant value of MD (2p=0.09), whereas no other variable approached statistical significance (2p≥0.25). In a multivariate Cox analysis, MF was the only parameter of significant independent prognostic value (2p=0.03). Thus, the prognostic value of nuclear features found in previous studies could not be reproduced, whereas the marked value of mitotic counts for prediction of the outcome in patients with breast cancer was confirmed. Mitotic counts are easily obtained and may be of clinical value for identification of high-risk cases among patients with lymph node-negative breast cancer.
Similar content being viewed by others
References
Aaltomaa S, Lipponen P, Eskelinen M, et al (1991) Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas. Eur J Cancer 27: 1555–1559
Andersen KW, Mouridsen HT (1988) Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 27: 627–647
Baak JPA, Dop H van, Kurver PHJ, Hermans J (1985) The value of morphometry to classic prognosticators in breast cancer. Cancer 56: 374–382
Baak JPA, Noteboom E, Koevoets JJM (1989) The influence of fixatives and other variations in tissue processing on nuclear morphometric features. Anal Quant Cytol Histol 11: 219–224
Biesterfeld S, Noll I, Noll E, Wohltmann D, Bocking A (1995) Mitotic frequency as a prognostic factor in breast cancer. Hum Pathol 26: 47–52
Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359–377
Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL (1989) Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320: 627–633
Clayton F (1991) Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor. Cancer 68: 1309–1317
Delides GS, Garas G, Georgouli G, et al (1982) Intralaboratory variations in the grading of breast carcinoma. Arch Pathol Lab Med 106: 126–128
Diest PJ van, Baak JPA (1991) The Morphometric Prognostic Index is the strongest prognosticator in premenopausal lymph node-negative and lymph node-positive breast cancer patients. Hum Pathol 22: 326–330
Diest PJ van, Baak JPA, Matze-Cok P et al (1992) Reproducibility of mitosis counting in 2469 breast cancer specimens. Results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23: 603–607
Early Breast Cancer Trialists' Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 339: 1–15, 71–85
Fisher B, Redmond C, Fisher ER, et al (1988) Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project protocol B-06. J Clin Oncol 6: 1076–1087
Gundersen HJG (1977) Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J Microsc 111: 219–223
Gundersen HJG, Jensen EB (1985) Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J Microsc 138: 127–142
Gundersen HJG, Østerby R (1980) Optimizing sampling efficiency of stereological studies in biology: or ‘Do more less well!’. J Microsc 121: 65–73
Hastie TJ, Tibshirani RJ (1990) Generalized additive models, 1st edn. Chapman and Hall, London
Helander KG (1983) Thickness variations within individual paraffin and glycol methacrylate sections. J Microsc 132: 223–227
Jannik I, Diest PJ van, Baak JPA (1994) Comparison of the prognostic value of mitotic activity index (MAI), random MAI (rMAI), volume weighted MAI, and volume weighted rMAI in breast cancer patients. Abstract presented at the 8th International Symposium on Diagnostic Quantitative Pathology, Amsterdam, September
Jensen V, Ladekarl M (1995) Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer. J Clin Pathol 48: 429–432
Jensen V, Ladekarl M, Holm-Nielsen P, Melsen F, Sørensen FB (1995) The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node negative breast cancer. J Pathol 176: 343–352
Ladekarl M (1994) The influence of tissue processing on quantitative histopathology in breast cancer. J Microsc 174: 93–100
Ladekarl M (1995) Quantitative histopathology in ductal carcinoma of the breast: prognostic value of mean nuclear size and mitotic counts. Cancer 75: 2114–2122
Ladekarl M, Sørensen FB (1993) Prognostic, quantitative histopathologic variables in lobular carcinoma of the breast. Cancer 72: 2602–2611
Laroye GJ, Minkin S (1991) The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status. Mod Pathol 4: 456–460
Mansour EG, Gray R, Shatila AH, et al (1989) Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med 320: 485–490
McCarty KS Jr, Barton TK, Fetter BF, et al (1980) Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma. Cancer 46: 2851–2858
Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 7:1239–1251
Rosner D, Lane WW (1991) Should all patients with node-negative breast cancer receive adjuvant therapy? Identifying additional subsets of low-risk patients who are highly curable by surgery alone. Cancer 68: 1482–1494
Sahin AA, Ro J, Ro JY, et al (1991) Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer 68: 549–557
Siitonen SM, Kallioniemi O-P, Isola JJ (1993) Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Am J Pathol 142: 1081–1089
Simpson JF, Dutt PL, Page DL (1992) Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol 23: 608–611
Sokal RR, Rohlf FJ (1981) Biometry. The principles and practice of statistics in biological research, 2nd edn. Freeman, New York
Spiessl B, Beahrs OH, Hermanek P, et al (1989) Breast tumours In: UICC International Union Against Cancer (ed): TNM atlas. Illustrated guide to the TNP/pTNM-classification of malignant tumours, 3rd edn. Springer, Berlin Heidelberg New York, pp 173–183
Start RD, Flynn MS, Cross SS, Rogers K, Smith JHF (1991) Is the grading of breast carcinomas affected by a delay in fixation? Virchows Arch [A] 419: 475–477
Stenkvist B, Westman-Naeser S, Vegelius J, Holmquist J, Nordin B, Bengtsson E, Eriksson O (1979) Analysis of reproducibility of subjective grading systems for breast carcinoma. J Clin Pathol 32: 979–985
Stierer M, Rosen H, Weber R (1991) Nuclear pleomorphism, a strong prognostic factor in axillary node-negative small invasive breast cancer. Breast Cancer Res Treat 20: 109–116
Sørensen FB (1992) Quantitative analysis of nuclear size for objective malignancy grading: a review with emphasis on new, unbiased stereologic methods. Lab Invest 66: 4–23
Theissig F, Kunze KD, Haroske G, Meyer W (1990) Histological grading of breast cancer. Interobserver reproducibility and prognostic significance. Pathol Res Pract 186: 732–736
Uyterlinde AM, Baak JPA, Schipper NW, Peterse H, Matze E, Meijer CJL (1990) Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast-cancer patients with long follow-up. Int J Cancer 45: 1–7
Verhoeven D, Bourgeois N, Derde MP, Kaufman L, Buyssens N (1990) Comparison of cell growth in different parts of breast cancers. Histopathology 17: 505–509
Winstanley J, Cooke T, George WD, et al (1991) The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast. Br J Cancer 64: 99–101
World Health Organization (1982) The World Health Organization histological typing of breast tumors, 2nd edn. Am J Clin Pathol 78: 806–816
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ladekarl, M., Jensen, V. Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts. Vichows Archiv A Pathol Anat 427, 265–270 (1995). https://doi.org/10.1007/BF00203393
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00203393